Login / Signup

Use of Calcitonin Gene-Related Peptide Monoclonal Antibodies for the Treatment of Migraines in Individuals With Multiple Sclerosis.

Ashley MasonLauren FragapaneZuleyma Toledo-NievesNatalie MoreoAngela AungstDerrick RobertsonJanice Maldonado
Published in: International journal of MS care (2024)
Our study showed a significant reduction in migraine frequency and a favorable adverse event profile for individuals with comorbid MS who took CGRP monoclonal antibodies and experienced no worsening of MS symptoms. In individuals with MS, CGRP monoclonal antibodies seem to be a safe and effective therapy for episodic or chronic migraine.
Keyphrases
  • multiple sclerosis
  • mass spectrometry
  • ms ms
  • white matter
  • genome wide
  • gene expression
  • copy number
  • dna methylation
  • combination therapy
  • physical activity
  • sleep quality
  • electronic health record